A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
van Bussel, Mark T. J., Awada, Ahmad, de Jonge, Maja J. A., Mau-Sørensen, Morten, Nielsen, Dorte, Schöffski, Patrick, Verheul, Henk M. W., Sarholz, Barbara, Berghoff, Karin, El Bawab, Samer, KuipersJournal:
British Journal of Cancer
DOI:
10.1038/s41416-020-01151-6
Date:
November, 2020
Fichier:
PDF, 796 KB
2020
File converter
Plus de résultats de recherche
More benefits 
